ReachMD

Jeanny Aragon-Ching, M.D., F.A.C.P. Biography: Jeanny B. Aragon-Ching, M.D., F.A.C.P. serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute in Fairfax, Virginia, United States with a joint academic appointment as Associate Professor of Medicine at Virginia Commonwealth University. She completed internship and residency at the Albert Einstein Medical Center in Philadelphia, Pennsylvania where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, Maryland, where she served as an Associate Investigator on varying trials involved with pharmacogenomics, and early drug discovery for prostate cancer. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology (SUO), Best of ASCO, American Urologic Association (AUA) and the ASCO Annual meetings. She was recruited to Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Symposium Program Planning Committee since 2017. Specifically, she served as Track Chair for the renal cell cancer track for the ASCO GU Scientific Planning committee for both 2017 and 2018 ASCO GU Cancers Symposium and as Track Chair for the urothelial carcinoma track for the ASCO GU Cancers Symposium 2019. She has served in the ASCO Cancer Education Committee GU non-prostate track from 2017 - 2019.